Author:
Mottet Nicolas,Bellmunt Joaquim,Bolla Michel,Joniau Steven,Mason Malcolm,Matveev Vsevolod,Schmid Hans-Peter,Van der Kwast Theo,Wiegel Thomas,Zattoni Filiberto,Heidenreich Axel
Reference90 articles.
1. EAU guidelines on prostate cancer;Heidenreich;Eur Urol,2008
2. Modified from Oxford Centre for Evidence-Based Medicine Levels of Evidence (May 2001). Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, and Martin Dawes since November 1998. CEBM Web site. http://www.pdptoolkit.co.uk/Files/ebm/cebm/Doing%20ebm/levels_of_evidence.htm. Accessed November 2010.
3. Hormonal therapy: historical perspective to future directions;McLeod;Urology,2003
4. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis;Seidenfeld;Ann Intern Med,2000
5. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer;Klotz;BJU Int,2008
Cited by
470 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献